Therefore, it is critical to examine whether dysregulation of MYCN protein stability caused by BAP1 depletion or mutation may affect the sensitivity of NB cells to Aurora Kinase A or BET inhibitors. This evidence concerns the gene AURKA and neuroblastoma.